文献速递消化、代谢与肾脏急症

子宫内膜异位症分型与卵巢癌风险

Endometriosis Typology and Ovarian Cancer Risk.
PubMed 文献 · JAMA · 2024-01-01
一句话结论基于犹他州人群队列,卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症女性的卵巢癌风险显著升高(aHR 9.66),尤其I型卵巢癌(aHR 18.96)。

该研究利用犹他州人群数据库构建人群队列,将78 893例子宫内膜异位症女性按1:5匹配无子宫内膜异位症女性,随访卵巢癌发生。结果显示,子宫内膜异位症女性总体卵巢癌风险升高(aHR 4.20,95%CI 3.59-4.91),I型卵巢癌风险尤高(aHR 7.48,95%CI 5.80-9.65)。卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症女性风险最高:全部卵巢癌aHR 9.66(95%CI 7.77-12.00),I型卵巢癌aHR 18.96(95%CI 13.78-26.08)。作者认为该人群可能受益于卵巢癌风险与预防咨询,并可作为靶向筛查与预防研究的重要人群。

要点

  • 子宫内膜异位症女性总体卵巢癌风险升高:aHR 4.20(95%CI 3.59-4.91),aRD 9.90/10 000(95%CI 7.22-12.57)。
  • I型卵巢癌风险升高更明显:aHR 7.48(95%CI 5.80-9.65),aRD 7.53/10 000(95%CI 5.46-9.61)。
  • 卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症女性全部卵巢癌aHR 9.66(95%CI 7.77-12.00),aRD 26.71/10 000(95%CI 20.01-33.41)。
  • 该亚组I型卵巢癌aHR 18.96(95%CI 13.78-26.08),aRD 19.57/10 000(95%CI 13.80-25.35);II型卵巢癌aHR 3.72(95%CI 2.31-5.98),aRD 2.42/10 000(95%CI -0.01至4.85)。
  • 作者认为卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症人群可能受益于卵巢癌风险与预防咨询,并可作为靶向筛查与预防研究的重要人群。

适用人群与场景

  • 犹他州人群数据库中的女性,包括78 893例子宫内膜异位症女性及按1:5匹配的无子宫内膜异位症女性。
  • 子宫内膜异位症通过电子健康记录识别,分为浅表型、卵巢子宫内膜瘤、深部浸润型或其他类型。
  • 首次子宫内膜异位症诊断平均(SD)年龄为36(10)岁。

研究设计与关键结果

  • 研究设计:基于犹他州人群数据库的人群队列研究,将78 893例子宫内膜异位症女性按1:5比例匹配无子宫内膜异位症女性。
  • 暴露:子宫内膜异位症通过电子健康记录识别,分为浅表型、卵巢子宫内膜瘤、深部浸润型或其他类型。
  • 主要终点:总体卵巢癌、I型卵巢癌和II型卵巢癌的 adjusted hazard ratios(aHRs)、每10 000女性的 adjusted risk differences(aRDs)及95% CIs,比较各型子宫内膜异位症女性与无子宫内膜异位症女性;模型校正社会人口学因素、生育史和既往妇科手术。
  • 队列中共有597例卵巢癌。
  • 子宫内膜异位症女性 vs 无子宫内膜异位症女性:总体卵巢癌 aHR 4.20(95%CI 3.59-4.91),aRD 9.90/10 000(95%CI 7.22-12.57);I型卵巢癌 aHR 7.48(95%CI 5.80-9.65),aRD 7.53/10 000(95%CI 5.46-9.61)。
  • 卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症女性:全部卵巢癌 aHR 9.66(95%CI 7.77-12.00),aRD 26.71/10 000(95%CI 20.01-33.41);I型卵巢癌 aHR 18.96(95%CI 13.78-26.08),aRD 19.57/10 000(95%CI 13.80-25.35);II型卵巢癌 aHR 3.72(95%CI 2.31-5.98),aRD 2.42/10 000(95%CI -0.01至4.85)。

证据类型、等级与局限

  • 证据类型:基于人群数据库的人群队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,卵巢子宫内膜瘤和/或深部浸润型子宫内膜异位症女性可能受益于卵巢癌风险与预防咨询。
  • 作者认为,该人群可作为靶向筛查与预防研究的重要人群。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

OBJECTIVE: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

EXPOSURES: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

MAIN OUTCOMES AND MEASURES: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

RESULTS: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

CONCLUSIONS AND RELEVANCE: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Barnard ME, Farland LV, Yan B, et al. Endometriosis Typology and Ovarian Cancer Risk. JAMA. 2024. PMID: 39018030. doi:10.1001/jama.2024.9210

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。